Shopping Cart
- Remove All
- Your shopping cart is currently empty
Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor that reduces the production of pro-inflammatory mediators and cytokines. Dovramilast is used in the study of Mycobacterium tuberculosis infections and lupus erythematosus.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $126 | In Stock | |
2 mg | $186 | In Stock | |
5 mg | $313 | In Stock | |
10 mg | $496 | In Stock | |
25 mg | $953 | In Stock | |
50 mg | $1,490 | In Stock |
Description | Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor that reduces the production of pro-inflammatory mediators and cytokines. Dovramilast is used in the study of Mycobacterium tuberculosis infections and lupus erythematosus. |
In vivo | In B6D2F1 mice, Dovramilast (5, 25, or 50 mg/kg; oral, single dose) reduces PDE4 expression in the lungs of mice infected with Mycobacterium tuberculosis (mtb)[1]. |
Alias | CC-11050 |
Molecular Weight | 472.55 |
Formula | C24H28N2O6S |
Cas No. | 340019-69-4 |
Smiles | CCOc1cc(ccc1OC)[C@@H](CS(C)(=O)=O)N1Cc2cccc(NC(=O)C3CC3)c2C1=O |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 15 mg/mL (31.74 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.